Back to top
more

Cigna Group (CI)

(Real Time Quote from BATS)

$273.58 USD

273.58
37,330

+2.58 (0.95%)

Updated Aug 8, 2025 10:08 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 5% (231 out of 244)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Factors that Make Molina Healthcare (MOH) an Attractive Bet Now

by Zacks Equity Research

Molina Healthcare (MOH) continues to ride on sustained top-line growth, well-performing Medicare and Medicaid businesses, and a strong cash position.

Zacks Equity Research

Cigna (CI) Divests Units to Chubb for Net $5.1 Billion

by Zacks Equity Research

Cigna (CI) closes the deal to divest its life, accident and supplemental benefits businesses to Chubb. CI primarily intends to pursue share repurchases with proceeds received from the transaction.

Zacks Equity Research

Should Invesco S&P 500 GARP ETF (SPGP) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for SPGP

Zacks Equity Research

Cigna (CI) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Cigna (CI) closed the most recent trading day at $259.68, moving +1.48% from the previous trading session.

Zacks Equity Research

Cigna (CI) Signs $3.5B Accelerated Share Buyback Agreements

by Zacks Equity Research

Cigna (CI) intends to buy back at least $7 billion worth of its stocks this year alone.

Zacks Equity Research

Cigna (CI) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Cigna (CI) closed at $248.30 in the latest trading session, marking a +0.49% move from the prior day.

Zacks Equity Research

Cigna (CI) Stock Moves -1.67%: What You Should Know

by Zacks Equity Research

Cigna (CI) closed the most recent trading day at $253.29, moving -1.67% from the previous trading session.

Zacks Equity Research

Here's Why Investors Should Bet on Cigna (CI) Stock Now

by Zacks Equity Research

Cigna (CI) expects 2022 medical customers to grow by a minimum of 725,000, suggesting an upside from the prior projection.

Zacks Equity Research

3 Reasons Growth Investors Will Love Cigna (CI)

by Zacks Equity Research

Cigna (CI) could produce exceptional returns because of its solid growth attributes.

Zacks Equity Research

Are Investors Undervaluing Cigna (CI) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

The Zacks Analyst Blog Highlights 3M, Cigna, UnitedHealth Group, Exxon Mobil, and ConocoPhillips

by Zacks Equity Research

3M, Cigna, UnitedHealth Group, Exxon Mobil, and ConocoPhillips are part of Zacks top Analyst Blog

Nalak Das headshot

Volatility Reigns Supreme on Wall Street: Top 5 Picks for June

by Nalak Das

We have narrowed our search to five U.S. corporate behemoths (market capital > $50 billion). These are: MMM, CI, UNH, XOM and COP.

Zacks Equity Research

Marsh & McLennan (MMC) Up 13.6% in a Year: More Room to Rally?

by Zacks Equity Research

Marsh & McLennan's (MMC) solid Risk and Insurance Services business is a major driver.

Zacks Equity Research

CI vs. BBSEY: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

CI vs. BBSEY: Which Stock Is the Better Value Option?

Zacks Equity Research

If You Invested $1000 in Cigna 10 Years Ago, This Is How Much You'd Have Now

by Zacks Equity Research

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

Zacks Equity Research

Is Assurant (AIZ) Outperforming Other Finance Stocks This Year?

by Zacks Equity Research

Here is how Assurant (AIZ) and Cigna (CI) have performed compared to their sector so far this year.

Zacks Equity Research

Aegon (AEG) to Sell 50% Stake in Spanish Insurance JV, Up 4.9%

by Zacks Equity Research

The Spanish insurance JV stake sale is expected to fetch Aegon (AEG) EUR 177 million from Unicaja Banco.

Zacks Equity Research

3 Reasons Why Cigna (CI) Is a Great Growth Stock

by Zacks Equity Research

Cigna (CI) possesses solid growth attributes, which could help it handily outperform the market.

Zacks Equity Research

The Zacks Analyst Blog Highlights Apple, Berkshire Hathaway, S&P Global, Comcast, and Cigna

by Zacks Equity Research

Apple, Berkshire Hathaway, S&P Global, Comcast, and Cigna are part of Zacks top Analyst Blog.

Sheraz Mian headshot

Top Analyst Reports for Apple, Berkshire Hathaway, & S&P Global

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), Berkshire Hathaway Inc. (BRK.B), and S&P Global Inc. (SPGI).

Zacks Equity Research

Humana (HUM) Expands JV, To Invest $1.2B, Eyes 100 New Clinics

by Zacks Equity Research

Through the first JV, Humana (HUM) and its partner are pumping $800 million into developing 67 facilities by early 2023.

Zacks Equity Research

Cigna Corporation (CI) Soars to 52-Week High, Time to Cash Out?

by Zacks Equity Research

Cigna (CI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Equity Research

Is Invesco S&P 500 Pure Value ETF (RPV) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for RPV

Zacks Equity Research

Is Cigna (CI) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Should Invesco S&P 500 Pure Value ETF (RPV) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for RPV